INS and diabetes mellitus: This problem severely restricts the therapeutic value of the drugs, particularly for diabetes, the case is more evident: less than 0.1% of the oral dose of insulin reaches the bloodstream intact [4]; thus, due to their excessive degradation, it must be administered through injections and in repeated doses to ensure their effect, which leads to poor patient compliance [5].